Androgen response to hypothalamic-pituitary-adrenal stimulation with naloxone in women with myotonic muscular dystrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 9, 1998, Pages 3219-3224

  Buyalos, R P ^a   Jackson, R V ^b   Grice, G I ^f   Hockings, G I ^b   Torpy, D J ^b,e   Fox, L M ^c   Boots, L R ^c   Azziz, R ^c,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; NALOXONE; PRASTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MUSCLE ATROPHY; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; PRIORITY JOURNAL;

EID: 0031770979     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.9.5078     Document Type: Article

References (45)

1. Azziz R, Bradley Jr E, Huth J, Parker Jr CR, Zacur HA. 1990 Acute adrenocorticotropin-(1-24) (ACTH) adrenal stimulation in eumenorrheic women: reproducibility and effect of ACTH dose, subject weight and sampling time. J Clin Endocrinol Metab. 70:1273-1279.
2. Avgerinos PC, Butler Jr, GB, Tsokos GC, et al. 1987 Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy. J Clin Endocrinol Metab. 65:24-29.
3. Parker Jr CR, Baxter CR. 1985 Divergence in adrenal steroid secretory pattern after thermal injury in adult patients. J Trauma. 25:508-510.
4. Lephart ED, Baxter CR, Parker Jr CR. 1987 Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab. 64:842-848.
5. Azziz R. 1992 Hirsutism. In: Carpenter SE, Rock JA, eds. Pediatric and adolescent gynecology, New York: Raven Press; 239-266.
6. Schiebinger RJ, Albertson BD, Cassorla FG, Bowyer DW, Geelhoed GW, Cutler Jr GB. 1981 The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. J Clin Invest. 67:1177-1182.
7. Grumbach MM, Richards GE, Conte FA, Kaplan SL. 1978 Clinical disorders of adrenal function and puberty: an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone. In: James VHT, Giusti Ms, Giusti G, Martini L, eds. The endocrine function of the human adrenal cortex, Proceedings of the Serono Symposia. New York: Academic Press; vol 18:583-612.
8. Parker LN, Odell WD. 1980 Control of adrenal androgen secretion. Endocr Rev. 1:392-410.
9. Parker L, Lifrak E, Shively, et al. Human adrenal gland cortical androgen-stimulating hormone (CASH) is identical with a portion of the joining peptide of pituitary pro-opiomelanocortin (POMC) [Abstract 299]. Proc of the 71st Annual Meet of The Endocrine Soc. 1989.
10. O'Connell Y, McKenna TJ, Cunningham SK. 1993 Effects of pro-opiomelanocortin-derived peptides on adrenal steroidogenesis in guinea-pig adrenal cells in vitro. J Steroid Biochem Mol Biol. 44:77-83.
11. Harris S, Moncrieff C, Johnson K. 1996 Myotonic dystrophy: will the real gene please step forward. Hum Mol Genet. 5:1417-1423.
12. Fu Y-H, Pizzuti A, Fenwick RG, et al. 1992 An unstable triple repeat in a gene related to myotonic muscular dystrophy. Science. 255:1256-1258.
13. Brook JD, McCurragh ME, Harley HG, et. al. 1992 Molecular basis of myotonic dystrophy: expansion of trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell. 68:799-808.
14. Madadevan M, Tsilfidis C, Sabourin L, et al. 1992 Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science. 255:1253-1255.
15. Lavedan C, Hofmann-Radvnyi H, Shelbourne P, et al. 1993 Myotonic dystrophy: size- and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet. 52:875-883.
16. Jansen G, Mahadevan M, Amemiya C, et al. 1992 Characterization of the myotonic dystrophy region predicts multiple protein isoforms encoding mRNAs. Nat Genet. 1:261-266.
17. Takahashi S, Miyamoto A, Oki J, Okuno A. 1996 CTG trinucleotide repeat length and clinical expression in a family with myotonic dystrophy. Brain Dev. 18:127-130.
18. Jackson RV, Fleming GA, Sussman CR, et al. 1988 Increased pro-opiomelanocrtin-derived peptide release in myotonic dystrophy. Aust Pediatr J. [Suppl 1] 24:70-73.
19. Grice JE, Jackson J, Hewett M, Penfold PJ, Jackson RV. 1991 Adrenocorticotropin hyperresponsiveness in myotonic dystrophy following oral fenfluramine administration. J Neuroendocrinol. 3:69-73.
20. Grice JE, Jackson RV, Hockings GI, Torpy DJ, Walters MM, Crosbie GV. 1995. Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophy. J Clin Endocrinol Metab. 80:179-184.
21. Carter JN, Steinbeck KS. 1985. Reduced adrenal androgens in patients with myotonic dystrophy. J Clin Endocrinol Metab. 60:611-614.
22. Zumoff B, Rosenfeld RS, Strain GW, Levin J, Fukushima DK. 1980 Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adult. J Clin Endocrinol Metab. 51:330-333.
23. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:551-555.
24. Jackson RV, Grice JE, Jackson AJ, Hockings GI. 1990 Naloxone-induced ACTH release in man is inhibited by clonidine. Clin Exp Pharmicol Physiol. 17:179-184.
25. Al-Damluji S. 1991 Measuring the activity of brain adrenergic receptors in man. J Endocrinol Invest. 14:245-254.
26. Grossman AE, Besser GM. 1982 Opiates control ACTH through a noradrenergic mechanism. Clin Endocrinol (Oxf). 17:287-290.
27. Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM, Jackson RV. 1995 The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion. J Clin Endocrinol Metab. 80:802-806.
28. Hockings GI, Grice JE, Walters MM, Crosbie GV, Torpy DJ, Jackson RV. 1995 A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone. Neuroendocrinology. 61:198-206.
29. Parker LN, Odell WM. 1980 Control of adrenal androgen secretion. Endocr Rev. 1:392-410.
30. Nicholson WE, Davis DR, Sherell BJ, Orth DN. 1984 Rapid radioimmunoassay for corticotropin in unextracted plasma. Clin Chem. 30:259-265.
31. Murphy BEP. 1970 Methodological problems in competitive protein-binding techniques: the use of Sephadex column chromatography to separate steroids. Acta Endocrinol (Copenh). [Suppl] 147:37-60.
32. Azziz R, Rittmaster RS, Fox LM, Bradley EL, Potter HD, Boots LR. 1998 The role of the ovary in the adrenal androgen excess of hyperandrogenic women Fertil Steril. 69:851-859.
33. Scott NR, Chakraborty J, Marks V. 1988 Determination of prednisolone, prednisone, and cortisol in human plasma by high-performance liquid chromatography. Anal Biochem. 108:266-268.
34. Tatro JB. 1996 Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation. 3:259-284.
35. Hockings GI, Grice JE, Crosbie GV, Walters MM, Jackson RV. 1993 Altered hypothalamic-pituitary responsiveness in myotonic dystrophy: in vitro evidence for abnormal dihydropyridine insensitive calcium transport. J Clin Endocrinol Metab. 76:1433-1438.
36. Kim YI, Neher E. 1988 IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science. 239:405-408.
37. Fong P, Turner PR, Denetclaw WF, Steinhardt RA. 1990 Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science. 250:673-676.
38. Morrone A, Pegoraro E, Angelini C, Zammarchi E, Marconi G, Hoffman EP. 1997 RNA metabolism in myotonic dystrophy. J Clin Invest. 99:1691-1698.
39. Wang J, Pegoraro E, Menegazzo E, et al. 1995. Myotonic dystrophy: evidence for a possible dominant negative RNA mutation. Hum Mol Genet. 4:599-606.
40. Parker CR Jr, Mixon RE, Brissie RM, Grizzle WE. 1997 Aging alters zonation in the adrenal cortex of men. J Clin Endocrinol Metab. 82:3898-3901.
41. Lephart ED, Baxter CR, Parker Jr CR. 1987 Effect of burn trauma on adrenal and testicular steroid hormone production. J Clin Endocrinol Metab. 64:842-848.
42. Wade CE, Lindberg JS, Cockrell JL, et al. 1988 Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metab. 67:223-227.
43. Zhang L, Rodriguez H, Ohino S, Miller W. 1995 Serine phosphorylation of human P450C17 increase 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci USA. 92:10619-10623.
44. Harper P, Penny R, Foley TP, et al. 1972 Gonadal function in males with myotonic dystrophy. J Clin Endocrinol Metab. 35:852-856.
45. Sagel J, Distiller LA, Morley JE, Isaacs H. 1975 Myotonia dystrophica: studies on gonadal function using luteinizing hormone-releasing hormone. J Clin Endocrinol Mtab. 40:1110-1113.